These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
152 related articles for article (PubMed ID: 12162678)
1. Polyclonal anti-PSA is more sensitive but less specific than monoclonal anti-PSA: Implications for diagnostic prostatic pathology. Varma M; Morgan M; Jasani B; Tamboli P; Amin MB Am J Clin Pathol; 2002 Aug; 118(2):202-7. PubMed ID: 12162678 [TBL] [Abstract][Full Text] [Related]
2. The role of P501S and PSA in the diagnosis of metastatic adenocarcinoma of the prostate. Sheridan T; Herawi M; Epstein JI; Illei PB Am J Surg Pathol; 2007 Sep; 31(9):1351-5. PubMed ID: 17721190 [TBL] [Abstract][Full Text] [Related]
3. Immunohistochemical differentiation of high-grade prostate carcinoma from urothelial carcinoma. Chuang AY; DeMarzo AM; Veltri RW; Sharma RB; Bieberich CJ; Epstein JI Am J Surg Pathol; 2007 Aug; 31(8):1246-55. PubMed ID: 17667550 [TBL] [Abstract][Full Text] [Related]
4. Immunocytochemical detection of prostate specific antigen expression in human primary and metastatic melanomas. Bodey B; Bodey B; Kaiser HE Anticancer Res; 1997; 17(3C):2343-6. PubMed ID: 9216712 [TBL] [Abstract][Full Text] [Related]
5. Immunohistochemical staining of precursor forms of prostate-specific antigen (proPSA) in metastatic prostate cancer. Parwani AV; Marlow C; Demarzo AM; Mikolajczyk SD; Rittenhouse HG; Veltri RW; Chan TY Am J Surg Pathol; 2006 Oct; 30(10):1231-6. PubMed ID: 17001152 [TBL] [Abstract][Full Text] [Related]
6. Immunohistochemical expression of prostate specific antigen (PSA) in benign and malignant tumors of the prostate. Dema A; Tudose N Rom J Morphol Embryol; 1998; 44(1-4):93-100. PubMed ID: 15678849 [TBL] [Abstract][Full Text] [Related]
7. Three immunoassays based on monoclonal antibodies specific for prostate specific antigen (PSA), alpha-1-antichymotrypsin (ACT), and the PSA-ACT complex. Wan XS; Xu YA; Ware JH; Kennedy AR Prostate; 2003 Jul; 56(2):131-41. PubMed ID: 12746838 [TBL] [Abstract][Full Text] [Related]
8. Profile of prostatic-specific antigen in prostatic carcinomas. Tomita T; Dalton T; Kwok S; Lee S; Noble M; Chiga M Mod Pathol; 1993 May; 6(3):259-64. PubMed ID: 7688461 [TBL] [Abstract][Full Text] [Related]
9. [Immunohistochemical study of neuroendocrine cells and prostate-specific antigen in prostate carcinoma]. Yao GY; Lai MD; Chen PH Zhonghua Yi Xue Za Zhi; 1994 Mar; 74(3):161-2, 191-2. PubMed ID: 7522941 [TBL] [Abstract][Full Text] [Related]
10. Immunocytochemical detection of prostate specific antigen expression in human breast carcinoma cells. Bodey B; Bodey B; Kaiser HE Anticancer Res; 1997; 17(4A):2577-81. PubMed ID: 9252683 [TBL] [Abstract][Full Text] [Related]
11. PSA and PAP as immunohistochemical markers in prostate cancer. Epstein JI Urol Clin North Am; 1993 Nov; 20(4):757-70. PubMed ID: 7505984 [TBL] [Abstract][Full Text] [Related]
12. Immunohistochemical expression of prostatic antigens in adenocarcinoma and villous adenoma of the urinary bladder. Lane Z; Hansel DE; Epstein JI Am J Surg Pathol; 2008 Sep; 32(9):1322-6. PubMed ID: 18670358 [TBL] [Abstract][Full Text] [Related]
13. Immunohistochemical characterization of two monoclonal antibodies, P25.48 and P25.91, which define a new prostate-specific antigen. Bazinet M; Cote RJ; Cordon-Cardo C; Myc A; Fair WR; Old LJ Cancer Res; 1988 Dec; 48(23):6938-42. PubMed ID: 2460231 [TBL] [Abstract][Full Text] [Related]
14. One-step immunostrip test for the simultaneous detection of free and total prostate specific antigen in serum. Fernández-Sánchez C; McNeil CJ; Rawson K; Nilsson O; Leung HY; Gnanapragasam V J Immunol Methods; 2005 Dec; 307(1-2):1-12. PubMed ID: 16277989 [TBL] [Abstract][Full Text] [Related]
15. The accumulation of angiostatin-like fragments in human prostate carcinoma. Migita T; Oda Y; Naito S; Morikawa W; Kuwano M; Tsuneyoshi M Clin Cancer Res; 2001 Sep; 7(9):2750-6. PubMed ID: 11555588 [TBL] [Abstract][Full Text] [Related]
16. [Improvement of total prostate specific antigen(PSA) assay from the "Skewed molar-response" to the "Equimolar-response" by utilizing anti free-PSA monoclonal antibodies]. Kimura E; Matsumoto K; Samori T Rinsho Byori; 2002 Feb; 50(2):202-6. PubMed ID: 11925860 [TBL] [Abstract][Full Text] [Related]
17. Selective recognition of enzymatically active prostate-specific antigen (PSA) by anti-PSA monoclonal antibodies. Michel S; Collomb-Clerc E; Geourjon C; Charrier JP; Passagot J; Courty Y; Deléage G; Jolivet-Reynaud C J Mol Recognit; 2005; 18(3):225-35. PubMed ID: 15593306 [TBL] [Abstract][Full Text] [Related]
18. [Differentiation of prostate cancer from benign prostatic disease by total prostate specific antigen dynamic profiles after transrectal prostate biopsy]. Shao Q; Song J; Zhou ZJ; Du LD Zhonghua Nan Ke Xue; 2008 Jul; 14(7):597-601. PubMed ID: 18686378 [TBL] [Abstract][Full Text] [Related]
19. Detecting prostate cancer by intracellular macrophage prostate-specific antigen (PSA): a more specific and sensitive marker than conventional serum total PSA. Herwig R; Mitteregger D; Djavan B; Kramer G; Margreiter M; Leers MP; Glodny B; Haider DG; Hörl WH; Marberger M Eur J Clin Invest; 2008 Jun; 38(6):430-7. PubMed ID: 18489403 [TBL] [Abstract][Full Text] [Related]
20. Small cell carcinoma of the prostate. A morphologic and immunohistochemical study of 95 cases. Wang W; Epstein JI Am J Surg Pathol; 2008 Jan; 32(1):65-71. PubMed ID: 18162772 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]